Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1Phase 1 1

Status

Completed 4

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Sarcoma 2Plasma cell 2Breast 2Other hematologic neoplasm 1Genitourinary 1

Conditions

Breast Neoplasms 67Prostatic Neoplasms 49Multiple Myeloma 29Neoplasm Metastasis 27Osteoporosis 16Pain 15Carcinoma, Non-Small-Cell Lung 10Neoplasms 9Lung Neoplasms 8Osteosarcoma 7Neoplasms, Plasma Cell 7Neuroblastoma 6Carcinoma, Renal Cell 6Bone Diseases, Metabolic 6Humoral Hypercalcemia Of Malignancy 5Bone Neoplasms 5Fractures, Bone 4Bone Diseases 4Sarcoma, Ewing 3Sarcoma 3Lymphoma 3Kidney Neoplasms 3Uterine Cervical Neoplasms 2Triple Negative Breast Neoplasms 2Spinal Cord Compression 2Small Cell Lung Carcinoma 2Rhabdomyosarcoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pleural Effusion, Malignant 2Ovarian Neoplasms 2

Interventions

Zoledronic Acid 4Denosumab 3Vitamin D 2saracatinib 1radium Ra 223 dichloride 1odanacatib 1etelcalcetide hydrochloride 1cabozantinib 1Standard of Care 1Progestins 1Pamidronate 1Paclitaxel 1Hormone Replacement Therapy 1Exercise 1Estrogens 1Estrogen Replacement Therapy 1Dietary Supplements 1Diet, Fat-Restricted 1Calcium 1BHQ880 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Bone Diseases × Zoledronic Acid × Clear all
NCT01345019 2022-11-08

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma

Amgen

Phase 3 Completed
1,718 enrolled 22 charts
Other hematologic neoplasmPlasma cellSarcoma

Blood Protein Disorders, Bone Diseases, Bone Marrow Diseases, Bone Neoplasms, Hematologic Diseases, Multiple Myeloma, Neoplasm Metastasis, Neoplasms, Neoplastic Processes, Paraproteinemias, Spinal Cord Compression, Hematologic Neoplasms, Fractures, Bone, Neoplasms, Plasma Cell

NCT00399802 2018-08-16

A Study to Examine the Effects of an Experimental Drug on Women With Breast Cancer and Metastatic Bone Disease (MBD)(0822-016)(COMPLETED)

Merck Sharp & Dohme LLC

Phase 2 Completed
43 enrolled 10 charts
Breast

Bone Diseases, Breast Neoplasms

NCT00558272 2013-05-27

Study to Evaluate the Safety and Effects AZD0530 on Prostate and Breast Cancer Subjects With Metastatic Bone Disease

AstraZeneca

Phase 2 Completed
139 enrolled 23 charts
BreastGenitourinarySarcoma

Bone Diseases, Bone Neoplasms, Breast Neoplasms, Prostatic Neoplasms

NCT00741377 2013-02-18

A Study to Assess BHQ880 in Combination With Zoledronic Acid in Relapsed or Refractory Myeloma Patients

Novartis

Phase 1 Completed
28 enrolled
Plasma cell

Bone Diseases, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡